Phytomedicine, Journal Year: 2025, Volume and Issue: 142, P. 156749 - 156749
Published: April 12, 2025
Language: Английский
Phytomedicine, Journal Year: 2025, Volume and Issue: 142, P. 156749 - 156749
Published: April 12, 2025
Language: Английский
Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 95, P. 102233 - 102233
Published: Feb. 14, 2024
Language: Английский
Citations
18Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 95, P. 102209 - 102209
Published: Jan. 28, 2024
Language: Английский
Citations
17Journal of Cellular and Molecular Medicine, Journal Year: 2024, Volume and Issue: 28(10)
Published: May 1, 2024
Parkinson's disease (PD) is a neurodegenerative disorder of the brain and manifested by motor non-motor symptoms because degenerative changes in dopaminergic neurons substantia nigra. PD neuropathology associated with mitochondrial dysfunction, oxidative damage apoptosis. Thus, modulation apoptosis growth factors could be novel boulevard management PD. Brain-derived neurotrophic factor (BDNF) its receptor tropomyosin kinase type B (TrkB) are chiefly involved neuropathology. BDNF promotes survival nigra enhances functional activity striatal neurons. Deficiency TrkB triggers degeneration accumulation α-Syn As well, BDNF/TrkB signalling reduced early phase Targeting specific activators may attenuate this review aimed to discuss potential role against In conclusion, decreased linked severity long-term complications. Activation
Language: Английский
Citations
17Molecular and Cellular Biochemistry, Journal Year: 2023, Volume and Issue: 479(4), P. 975 - 991
Published: June 2, 2023
Language: Английский
Citations
41Pharmacology Research & Perspectives, Journal Year: 2023, Volume and Issue: 11(2)
Published: Feb. 22, 2023
Parkinson's disease (PD) is the second most frequent neurodegenerative brain (NBD) after Alzheimer's (AD). Statins are common lipid-lowering agents used in management of dyslipidemia and prevention primary secondary cardiovascular diseases (CVD) events. In addition, there a controversial point regarding role serum lipids pathogenesis PD. this bargain, as statins reduce cholesterol so they affect PD neuropathology bidirectional ways either protective or harmful. not PD, but frequently disorders commonly associated with elderly population. Therefore, use that population may outcomes. Concerning potential on neuropathology, conflicts controversies against development harmful by increasing risk for review aimed to clarify precise pros cons from published studies. Many studies suggest through modulation inflammatory lysosomal signaling pathways. Nevertheless, other observations statin therapy increase diverse mechanisms including reduction CoQ10. conclusion, strong neuropathology. retrospective prospective necessary regard.
Language: Английский
Citations
39Autophagy, Journal Year: 2023, Volume and Issue: 20(2), P. 259 - 274
Published: Sept. 15, 2023
Multiple sclerosis (MS) is a chronic progressive demyelinating disease of the central nervous system (CNS) due to an increase abnormal peripherally auto-reactive T lymphocytes which elicit autoimmunity. The main pathophysiology MS myelin sheath damage by immune cells and defect in generation oligodendrocytes. Macroautophagy/autophagy critical degradation process that eliminates dysfunctional or superfluous cellular components. Autophagy has property double-edged sword it may have both beneficial detrimental effects on neuropathology. Therefore, this review illustrates protective harmful autophagy with regard disease. prevents progression reducing oxidative stress inflammatory disorders. In contrast, over-activated associated neuropathology case use inhibitors alleviate pathogenesis MS. Furthermore, provokes activation different supporting play intricate role functions modulation regulating cell proliferation related demyelination remyelination. enhances remyelination increasing activity oligodendrocytes, astrocytes. However, induces activating microglia cells. conclusion, specific autophagic activators astrocytes, dendritic (DCs), induce against
Language: Английский
Citations
37Ageing Research Reviews, Journal Year: 2023, Volume and Issue: 91, P. 102084 - 102084
Published: Oct. 5, 2023
Language: Английский
Citations
35Inflammopharmacology, Journal Year: 2023, Volume and Issue: 31(4), P. 1671 - 1682
Published: May 9, 2023
Language: Английский
Citations
31Ageing Research Reviews, Journal Year: 2023, Volume and Issue: 92, P. 102119 - 102119
Published: Nov. 4, 2023
Language: Английский
Citations
26Ageing Research Reviews, Journal Year: 2023, Volume and Issue: 91, P. 102075 - 102075
Published: Sept. 14, 2023
Language: Английский
Citations
23